Clinical pharmacology of polyethylene glycol-L-asparaginase

Drug Metabolism and Disposition

Volumn 14, Issue 3, 1986, Pages 349-352

  Ho, D H ^a   Brown, N S ^a   Yen, A ^a   Holmes, R ^b   Keating, M ^b   Abuchowski, A ^b   Newman, R A ^b   Krakoff, I H ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; MACROGOL;

BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG THERAPY; ENZYME BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; PHARMACOKINETICS; PHARMACOLOGY; PRIORITY JOURNAL; THERAPY;

ADULT; AGED; ANAPHYLAXIS; ASPARAGINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; FEMALE; HUMANS; INFUSIONS, PARENTERAL; KINETICS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; LYMPHOMA; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS;

EID: 0022922655     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)